The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria

<p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liv...

Full description

Bibliographic Details
Main Author: Gola, A
Other Authors: Spencer, A
Format: Thesis
Language:English
Published: 2018
Subjects:
_version_ 1817933056344850432
author Gola, A
author2 Spencer, A
author_facet Spencer, A
Gola, A
author_sort Gola, A
collection OXFORD
description <p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liver stages of the Plasmodium falciparum lifecycle. To date, the greatest immunogenicity has been obtained through a heterologous prime boost regimen, where vaccination with an Adenoviral vector is followed 8 weeks later by a Modified Vaccinia Ankara virus (MVA) boost. Experimental work directed at providing a greater understanding of CD8<sup>+</sup> T-cell memory responses induced by Ad-MVA vaccinations lead to the development of a novel vaccine strategy aimed at priming CD8<sup>+</sup> T-cells in the periphery and subsequently targeting them to hepatic tissue with protein loaded poly(lactic- co-glycolic acid) nanoparticles or recombinant viral vectors. Durable Ag-specific CD8+ T- cells exhibiting a phenotype of tissue-resident memory T-cells were generated in the liver, with a ten-fold increase over the conventional heterologous vector regimen. Importantly, in P. berghei sporozoite challenge models of liver-stage malaria, this strategy was found to result in unprecedented levels of sterile protection across multiple clinically relevant antigens and mouse strains. This prime and target immunization strategy for liver-stage malaria may provide a novel general approach for prevention or immunotherapy against other hepato-trophic pathogens.</p>
first_indexed 2024-03-06T21:50:34Z
format Thesis
id oxford-uuid:4b1ce436-316f-43da-bacf-3b1e178f2f40
institution University of Oxford
language English
last_indexed 2024-12-09T03:47:44Z
publishDate 2018
record_format dspace
spelling oxford-uuid:4b1ce436-316f-43da-bacf-3b1e178f2f402024-12-08T10:30:09ZThe role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malariaThesishttp://purl.org/coar/resource_type/c_db06uuid:4b1ce436-316f-43da-bacf-3b1e178f2f40VaccinologyImmunologyLiver-Stage MalariaEnglishORA Deposit2018Gola, ASpencer, AHill, AGermain, R<p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liver stages of the Plasmodium falciparum lifecycle. To date, the greatest immunogenicity has been obtained through a heterologous prime boost regimen, where vaccination with an Adenoviral vector is followed 8 weeks later by a Modified Vaccinia Ankara virus (MVA) boost. Experimental work directed at providing a greater understanding of CD8<sup>+</sup> T-cell memory responses induced by Ad-MVA vaccinations lead to the development of a novel vaccine strategy aimed at priming CD8<sup>+</sup> T-cells in the periphery and subsequently targeting them to hepatic tissue with protein loaded poly(lactic- co-glycolic acid) nanoparticles or recombinant viral vectors. Durable Ag-specific CD8+ T- cells exhibiting a phenotype of tissue-resident memory T-cells were generated in the liver, with a ten-fold increase over the conventional heterologous vector regimen. Importantly, in P. berghei sporozoite challenge models of liver-stage malaria, this strategy was found to result in unprecedented levels of sterile protection across multiple clinically relevant antigens and mouse strains. This prime and target immunization strategy for liver-stage malaria may provide a novel general approach for prevention or immunotherapy against other hepato-trophic pathogens.</p>
spellingShingle Vaccinology
Immunology
Liver-Stage Malaria
Gola, A
The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title_full The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title_fullStr The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title_full_unstemmed The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title_short The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
title_sort role of antigen in the maintenance and localisation of cd8 t cells in the context of liver stage malaria
topic Vaccinology
Immunology
Liver-Stage Malaria
work_keys_str_mv AT golaa theroleofantigeninthemaintenanceandlocalisationofcd8tcellsinthecontextofliverstagemalaria
AT golaa roleofantigeninthemaintenanceandlocalisationofcd8tcellsinthecontextofliverstagemalaria